Results 1 to 10 of about 6,346 (180)
Ocular myasthenia gravis management [PDF]
Frontiers in NeurologyOcular myasthenia gravis (OMG) has no agreed-upon diagnostic and management criteria, leading to misdiagnoses and often misguided treatments. The purpose of this minireview is to provide guidance to clinicians who encounter possible OMG patients. We cite
Henry J Kaminski +2 more
exaly +6 more sources
Ocular myasthenia gravis in a setting of thyrotoxicosis
Indian Journal of Endocrinology and Metabolism, 2013 Ocular myasthenia gravis in conjunction with thyroid disorders, although rare, has been reported in the past. However, the similarity in the presentation of both the entities and the tendency of myasthenia gravis to get overlooked easily, even by ...
Sarabjeet Chhabra, B C Pruthvi
doaj +3 more sources
Ocular myasthenia gravis: A review
Indian Journal of Ophthalmology, 2014 Myasthenia gravis (MG) is a disease that affects the neuro-muscular junction resulting in classical symptoms of variable muscle weakness and fatigability. It is called the great masquerader owing to its varied clinical presentations.
Akshay Gopinathan Nair +3 more
doaj +3 more sources
Seronegative Maternal Ocular Myasthenia Gravis and Delayed Transient Neonatal Myasthenia Gravis
AJP Reports, 2016 Background Myasthenia gravis (MG) is an autoimmune disorder with fluctuating muscle weakness, divided into generalized and localized (ocular) forms.
Naveed Hussain, Winston A Campbell
exaly +3 more sources
Add-On Telitacicept Significantly Improves Outcome of Patients With Refractory Ocular Myasthenia Gravis a Real-World Case Series. [PDF]
Brain BehavIntroduction Refractory ocular myasthenia gravis (MG) represents a significant therapeutic challenge, as conventional immunotherapies often prove ineffective.
Lin J, Li Y, Gui M, Bu B, Li Z.
europepmc +2 more sources
Outcomes of Treatment in Ocular Myasthenia Gravis Based on Minimal Manifestation: A Real-World Retrospective Cohort Study. [PDF]
Clin OphthalmolParinee Kemchoknatee,1 Boonravee Santitamrongvtit,2 Thansit Srisombut3 1Department of Ophthalmology, Rajavithi Hospital, Rangsit University, Bangkok, Thailand; 2Department of Medicine, Phra Nang Klao Hospital, Nonthaburi, Thailand; 3Department of ...
Kemchoknatee P +2 more
europepmc +2 more sources
Frontiers in Pediatrics, 2022 Myasthenia gravis is an organ-specific autoimmune disease. Currently there is no universal guidelines for childhood-onset myasthenia gravis, therefore, treatment strategies are usually based on the guidelines from adult myasthenia gravis patients.
Lifen Yang +6 more
doaj +1 more source
American Journal of Ophthalmology Case Reports, 2023 Purpose: This is a case of myasthenic incomplete ophthalmoplegia mimicking a partial cranial nerve 3 palsy both subjectively and objectively improving after treatment with eculizumab.
Sara L. Weidmayer, Gary Gallagher
doaj +1 more source
Concentric Needle Jitter in 97 Myasthenia Gravis Patients
Frontiers in Neurology, 2020 Objectives: To estimate the jitter parameters (single-fiber electromyography) in myasthenia gravis patients mostly by electrical activation in Frontalis, Orbicularis Oculi, and Extensor Digitorum muscles using a concentric needle electrode.Methods ...
João Aris Kouyoumdjian +2 more
doaj +1 more source
Controversies in Ocular Myasthenia Gravis [PDF]
Frontiers in Neurology, 2020 Myasthenia gravis (MG) with symptoms limited to eye muscles [ocular MG (OMG)] is a rare disease. OMG incidence varies according to ethnicity and age of onset. In recent years, both an increase in incidence rate, particularly in the elderly, and a lower risk for secondary generalization may have contributed to the growing disease prevalence in Western ...
Amelia Evoli +3 more
openaire +3 more sources